Michael Offin, Xiaoling Zeng, Shenqi Wang, Bingying Xie, Melina Elpi Marmarelis. "Volrustomig, a novel bispecific PD-1/CTLA-4 monoclonal antibody, as single-agent first-line therapy for unresectable pleural mesothelioma: Substudy 5 of the eVOLVE-02 phase 2 study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps8126